SRSF2 and chronic myelomonocytic leukemia: CMML is the most common of MDS/MPNs with a characteristic hallmark of high frequency in somatic mutations in TET2, SRSF2, and ASXL, with an estimated 60%, 50%, and 40%, respectively [61,62].